Platelets take part in primary hemostasis, forming the initial plug that stops bleeding.
US reports give platelets per microliter (or per mm³); many other countries use ×10⁹/L: 150,000–400,000 per µL equals 150–400 × 10⁹/L.
Platelets take part in primary hemostasis, forming the initial plug that stops bleeding. Bleeding risk does not appear until clearly low counts: below 50,000/µL (50 × 10⁹/L) invasive procedures are limited, and below 20,000/µL there may be spontaneous bleeding.
Next: Hemoglobin · White blood cell count · INR and prothrombin time
By far the most frequent cause. It appears in inflammation, infection, iron deficiency, the postoperative period and after splenectomy, and does not significantly increase thrombotic risk.
A myeloproliferative neoplasm with autonomous platelet production, often with a JAK2 mutation and with a real risk of thrombosis.
The first thing to rule out: platelet clumping in the EDTA tube gives a falsely low count. It is resolved by repeating the draw in a citrate tube and reviewing the smear.
Heparin, chemotherapy, some antibiotics and antiepileptics, and alcohol use. Heparin-induced thrombocytopenia is paradoxical, because it produces thrombosis and not bleeding.
Immune thrombocytopenic purpura, lupus and viral infections destroy platelets peripherally with a preserved bone marrow.
Cirrhosis with portal hypertension produces splenic sequestration and less thrombopoietin; it is one of the most frequent causes of sustained thrombocytopenia.
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome combine thrombocytopenia, anemia with schistocytes and high LDH, and are an emergency.
The reading depends on whether all three lines or only platelets are affected. Isolated thrombocytopenia points to peripheral destruction or drugs; pancytopenia, to the bone marrow. The combination of thrombocytopenia with anemia and high LDH requires ruling out a microangiopathy immediately.
Below 50,000/µL invasive procedures are limited, and below 20,000/µL spontaneous bleeding may appear. Between 100,000 and 150,000/µL the bleeding risk is practically nil.
A falsely low count produced because platelets clump inside the EDTA tube. It is suspected when the result does not fit the absence of signs of bleeding, and is confirmed by reviewing the smear and repeating the draw with another anticoagulant.
This page is educational material for medical training: it describes the clinical meaning of the test and the causes of its abnormalities. It is not a diagnosis or a treatment recommendation, and it does not replace the laboratory report or the individual clinical assessment, which interprets each result in its context.